Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 776

1.
2.

Is breast cancer risk the same for all progestogens?

Stute P.

Arch Gynecol Obstet. 2014 Aug;290(2):207-9. doi: 10.1007/s00404-014-3270-0.

PMID:
24838289
[PubMed - indexed for MEDLINE]
3.

Insulin resistance and medial prefrontal gyrus metabolism in women receiving hormone therapy.

Rasgon NL, Kenna HA, Wroolie TE, Williams KE, DeMuth BN, Silverman DH.

Psychiatry Res. 2014 Jul 30;223(1):28-36. doi: 10.1016/j.pscychresns.2014.04.004. Epub 2014 Apr 15.

PMID:
24819305
[PubMed - indexed for MEDLINE]
4.

Systemic delivery of estradiol, but not testosterone or progesterone, alters very low density lipoprotein-triglyceride kinetics in postmenopausal women.

Smith GI, Reeds DN, Okunade AL, Patterson BW, Mittendorfer B.

J Clin Endocrinol Metab. 2014 Jul;99(7):E1306-10. doi: 10.1210/jc.2013-4470. Epub 2014 Apr 2.

PMID:
24694337
[PubMed - indexed for MEDLINE]
5.

Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study.

Botelho MA, Queiroz DB, Barros G, Guerreiro S, Fechine P, Umbelino S, Lyra A, Borges B, Freitas A, Queiroz DC, Ruela R, Almeida JG, Quintans L Jr.

Clinics (Sao Paulo). 2014 Feb;69(2):75-82. doi: 10.6061/clinics/2014(02)01.

PMID:
24519196
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.

Santen RJ, Kagan R, Altomare CJ, Komm B, Mirkin S, Taylor HS.

J Clin Endocrinol Metab. 2014 Mar;99(3):733-47. doi: 10.1210/jc.2013-3680. Epub 2014 Jan 1. Review.

PMID:
24423357
[PubMed - indexed for MEDLINE]
7.

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.

Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A.

Epidemiol Rev. 2014;36(1):114-36. doi: 10.1093/epirev/mxt010. Review.

PMID:
24375928
[PubMed - indexed for MEDLINE]
8.

Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France.

Cordina-Duverger E, Truong T, Anger A, Sanchez M, Arveux P, Kerbrat P, Guénel P.

PLoS One. 2013 Nov 1;8(11):e78016. doi: 10.1371/journal.pone.0078016. eCollection 2013.

PMID:
24223752
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: a Cochrane review summary.

Roberts H, Hickey M, Lethaby A.

Maturitas. 2014 Jan;77(1):4-6. doi: 10.1016/j.maturitas.2013.10.002. Epub 2013 Oct 11. No abstract available.

PMID:
24182544
[PubMed - indexed for MEDLINE]
10.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
[PubMed - indexed for MEDLINE]
11.

Sex hormone levels and risk of breast cancer with estrogen plus progestin.

Farhat GN, Parimi N, Chlebowski RT, Manson JE, Anderson G, Huang AJ, Vittinghoff E, Lee JS, Lacroix AZ, Cauley JA, Jackson R, Grady D, Lane DS, Phillips L, Simon MS, Cummings SR.

J Natl Cancer Inst. 2013 Oct 2;105(19):1496-503. doi: 10.1093/jnci/djt243. Epub 2013 Sep 16.

PMID:
24041978
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Progestin effects on cell proliferation pathways in the postmenopausal mammary gland.

Wood CE, Branstetter D, Jacob AP, Cline JM, Register TC, Rohrbach K, Huang LY, Borgerink H, Dougall WC.

Breast Cancer Res. 2013;15(4):R62.

PMID:
23938070
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
14.

Impact of hormone therapy on quality of life after menopause.

Utian WH, Woods NF.

Menopause. 2013 Oct;20(10):1098-105. doi: 10.1097/GME.0b013e318298debe. Review.

PMID:
23799357
[PubMed - indexed for MEDLINE]
15.

Association of oxidative stress and memory performance in postmenopausal women receiving estrogen-progestin therapy.

Shafin N, Zakaria R, Hussain NH, Othman Z.

Menopause. 2013 Jun;20(6):661-6. doi: 10.1097/GME.0b013e31827758c6.

PMID:
23715378
[PubMed - indexed for MEDLINE]
16.

ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism.

American College of Obstetricians and Gynecologists.

Obstet Gynecol. 2013 Apr;121(4):887-90. doi: 10.1097/01.AOG.0000428645.90795.d9.

PMID:
23635705
[PubMed - indexed for MEDLINE]
18.

Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.

Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL.

J Natl Cancer Inst. 2013 Apr 17;105(8):526-35. doi: 10.1093/jnci/djt043. Epub 2013 Mar 29.

PMID:
23543779
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effect of various forms of postmenopausal hormone therapy on the risk of ovarian cancer--a population-based case control study from Finland.

Koskela-Niska V, Pukkala E, Lyytinen H, Ylikorkala O, Dyba T.

Int J Cancer. 2013 Oct 1;133(7):1680-8. doi: 10.1002/ijc.28167. Epub 2013 Apr 16.

PMID:
23526244
[PubMed - indexed for MEDLINE]
20.

Mechanisms of hormonal therapy related thrombosis.

Sandset PM.

Thromb Res. 2013 Jan;131 Suppl 1:S4-7. doi: 10.1016/S0049-3848(13)70009-4. Review.

PMID:
23452740
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk